Evidence map›Paper›PMID 39056804›Full record

ReviewCells2024

Controlling the Expression Level of the Neuronal Reprogramming Factors for a Successful Reprogramming Outcome.

Natalie Mseis-Jackson, Mehek Sharma, Hedong Li

Abstract readReview
In one paragraph

Review in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Natalie Mseis-JacksonDepartment of Neuroscience & Regenerative Medicine, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
Mehek SharmaDepartment of Biological Sciences, College of Science & Mathematics, Augusta University, Augusta, GA 30912, USA.ORCID 0009-0004-9487-1647
Hedong LiDepartment of Neuroscience & Regenerative Medicine, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.ORCID 0000-0002-9814-1201

Funding

MicroRNA Function During Neuronal Reprogramming in Treating Spinal Cord InjuryR01NS117918 · NINDS · AUGUSTA UNIVERSITY · PI LI, HEDONG · 2020 to 2024
$1.8M
In Vivo Reprogramming Reactive Astrocytes into Functional Neuorons by MicroRNA-124 in the Injured Spinal CordR21NS104394 · NINDS · PENNSYLVANIA STATE UNIVERSITY, THE · PI LI, HEDONG · 2018 to 2019
$440k
Manipulating NeuroD1 expression by MicroRNAs to Optimize Neuronal Conversion for Spinal Cord Injury RepairR21NS119732 · NINDS · AUGUSTA UNIVERSITY · PI LI, HEDONG · 2021 to 2022
$424k
NINDS NIH HHS R01 NS117918NINDS NIH HHS R01NS117918NINDS NIH HHS R21 NS104394NINDS NIH HHS R21NS104394NINDS NIH HHS R21 NS119732NINDS NIH HHS R21NS119732
6 · The paper itself

Abstract

Neuronal reprogramming is a promising approach for making major advancement in regenerative medicine. Distinct from the approach of induced pluripotent stem cells, neuronal reprogramming converts non-neuronal cells to neurons without going through a primitive stem cell stage. In vivo neuronal reprogramming brings this approach to a higher level by changing the cell fate of glial cells to neurons in neural tissue through overexpressing reprogramming factors. Despite the ongoing debate over the validation and interpretation of newly generated neurons, in vivo neuronal reprogramming is still a feasible approach and has the potential to become clinical treatment with further optimization and refinement. Here, we discuss the major neuronal reprogramming factors (mostly pro-neurogenic transcription factors during development), especially the significance of their expression levels during neurogenesis and the reprogramming process focusing on NeuroD1. In the developing central nervous system, these pro-neurogenic transcription factors usually elicit distinct spatiotemporal expression patterns that are critical to their function in generating mature neurons. We argue that these dynamic expression patterns may be similarly needed in the process of reprogramming adult cells into neurons and further into mature neurons with subtype identities. We also summarize the existing approaches and propose new ones that control gene expression levels for a successful reprogramming outcome.

Indexed as

Cellular ReprogrammingNeuronsAnimalsHumansInduced Pluripotent Stem CellsNeurogenesisTranscription FactorsTranscription FactorsAscl1microRNANeuroD1neuronal reprogrammingNgn2Sox2

Identifiers

PMID39056804
PMCPMC11274869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.